Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

Resistance to targeted cancer drugs is thought to result from selective pressure exerted by a high drug dose. Partial inhibition of multiple components in the same oncogenic signalling pathway may add up to complete pathway inhibition, while decreasing the selective pressure on each component to acq...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes Neto, João M., Nadal, Ernest, Bosdriesz, Evert, Ooft, Salo N., Farre, Lourdes, McLean, Chelsea, Klarenbeek, Sjoerd, Jurgens, Anouk, Hagen, Hannes, Wang, Liqin, Felip, Enriqueta, Martinez-Marti, Alex, Vidal, August, Voest, Emile, Wessels, Lodewyk F. A., van Tellingen, Olaf, Villanueva, Alberto, Bernards, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308397/
https://www.ncbi.nlm.nih.gov/pubmed/32572029
http://dx.doi.org/10.1038/s41467-020-16952-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308397/
https://www.ncbi.nlm.nih.gov/pubmed/32572029
http://dx.doi.org/10.1038/s41467-020-16952-9

Ejemplares similares